Oh Chad has filed 9 insider transactions across 1 company since July 2023.
Most recent transaction: a grant/award of 862500 shares of AEON Biopharma, Inc. ($AEON) on February 17, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 17, 2026 | AEON Biopharma, Inc. | $AEON | Oh Chad | CHIEF MEDICAL OFFICER | A | Class A Common Stock | 862500 | $0.00 | 866,564.0000 | 11,634,946 | 9999.99% | 7.41% |
| March 4, 2026 | AEON Biopharma, Inc. | $AEON | Oh Chad | CHIEF MEDICAL OFFICER | A | Class A Common Stock | 1316872 | $0.00 | 2,183,436.0000 | 11,634,946 | 151.96% | 11.32% |
| May 21, 2025 | AEON Biopharma, Inc. | $AEON | Oh Chad | Chief Medical Officer | A | Restricted Stock Units | 1316872 | $0.00 | 1,316,872.0000 | 3,984,876 | 9999.99% | 33.05% |
| Aug. 31, 2024 | AEON Biopharma, Inc. | $AEON | Oh Chad | CHIEF MEDICAL OFFICER | A | Stock Option | 512673 | $0.00 | 512,673.0000 | 539,840 | 9999.99% | 94.97% |
| Aug. 31, 2024 | AEON Biopharma, Inc. | $AEON | Oh Chad | CHIEF MEDICAL OFFICER | A | Class A Common Stock | 192117 | $0.00 | 292,545.0000 | 539,840 | 191.30% | 35.59% |
| March 19, 2024 | AEON Biopharma, Inc. | $AEON | Oh Chad | CHIEF MEDICAL OFFICER | A | Stock Option | 86720 | $0.00 | 86,720.0000 | 516,404 | 9999.99% | 16.79% |
| July 21, 2023 | AEON Biopharma, Inc. | $AEON | Oh Chad | Chief Medical Officer | A | Stock Option | 145588 | $0.00 | 145,588.0000 | 138,825,356 | 9999.99% | 0.10% |
| July 21, 2023 | AEON Biopharma, Inc. | $AEON | Oh Chad | Chief Medical Officer | A | Stock Option | 115151 | $0.00 | 115,151.0000 | 138,825,356 | 9999.99% | 0.08% |
| July 21, 2023 | AEON Biopharma, Inc. | $AEON | Oh Chad | Chief Medical Officer | A | Restricted Stock Units | 100428 | $0.00 | 100,428.0000 | 138,825,356 | 9999.99% | 0.07% |